Company Filing History:
Years Active: 1997-2003
Title: The Innovative Contributions of Ivan Habus
Introduction
Ivan Habus is a notable inventor based in Shrewsbury, Massachusetts. He has made significant contributions to the field of oligonucleotide synthesis, holding a total of 11 patents. His work focuses on developing novel methods and synthons that enhance the efficiency and effectiveness of oligonucleotide production.
Latest Patents
Among his latest patents is the invention titled "Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom." This invention provides synthons containing a novel carbamate internucleoside linkage, along with methods for using these synthons to create oligonucleotides that incorporate these innovative linkages. Another significant patent is "Base protecting groups and synthons for oligonucleotide synthesis." This invention introduces new methods for synthesizing oligonucleotides that allow for deprotection under milder conditions than existing methods. It also presents a nucleoside base protecting group that remains stable during oligonucleotide synthesis but can be removed under gentler conditions compared to current protecting groups.
Career Highlights
Ivan Habus has established himself as a key figure in his field through his innovative research and development efforts. His work at Hybridon, Inc. has been instrumental in advancing the science of oligonucleotide synthesis. His contributions have not only enhanced the understanding of nucleic acid chemistry but have also paved the way for new applications in biotechnology and medicine.
Collaborations
Throughout his career, Ivan has collaborated with esteemed colleagues such as Sudhir Agrawal and Radhakrishnan P Iyer. These collaborations have further enriched his research and have led to the development of groundbreaking technologies in the field.
Conclusion
Ivan Habus is a distinguished inventor whose work has significantly impacted the field of oligonucleotide synthesis. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and technology. His contributions continue to influence the landscape of biotechnology and medicine.